Jon Rees

Jon joined as a trustee in 2021 and takes a special interest in translational PKD research which might one day lead to more effective treatments for PKD as well as governance.

Professionally Jon has experience in biopharma, finance and non-profit roles, including having consulted for a top 10 global pharmaceutical company helping them identify new rare disease science across Europe, and currently leads a start-up biotech company spun-out of a UK university.

Jon enjoys open air and coldwater swimming, is an enthusastic home sourdough baker and enjoys international cinema.